| Smartphone medication adherence apps: potential benefits to patients and providers L Dayer, S Heldenbrand, P Anderson, PO Gubbins, BC Martin Journal of the American Pharmacists Association 53 (2), 172-181, 2013 | 574 | 2013 |
| Population mobility, globalization, and antimicrobial drug resistance DW MacPherson, BD Gushulak, WB Baine, S Bala, PO Gubbins, P Holtom, ... Emerging infectious diseases 15 (11), 1727, 2009 | 225 | 2009 |
| Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients PO Gubbins, G Krishna, A Sansone-Parsons, SR Penzak, L Dong, ... Antimicrobial agents and chemotherapy 50 (6), 1993-1999, 2006 | 172 | 2006 |
| Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? SA McConnell, PO Gubbins, EJ Anaissie Clinical infectious diseases 37 (1), 65-72, 2003 | 135 | 2003 |
| Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses KM Olsen, G San Pedro, LP Gann, PO Gubbins, DM Halinski, ... Antimicrobial agents and chemotherapy 40 (11), 2582-2585, 1996 | 133 | 1996 |
| Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy PO Gubbins, ME Klepser, AM Dering-Anderson, KA Bauer, KM Darin, ... Journal of the American Pharmacists Association 54 (2), 163-171, 2014 | 104 | 2014 |
| Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis JR Bariola, CA Hage, M Durkin, E Bensadoun, PO Gubbins, LJ Wheat, ... Diagnostic microbiology and infectious disease 69 (2), 187-191, 2011 | 99 | 2011 |
| Developing and sustaining a culture of scholarship RH Kennedy, PO Gubbins, M Luer, IK Reddy, KE Light Am J Pharm Educ 67 (3), 92, 2003 | 86 | 2003 |
| Drug absorption in gastrointestinal disease and surgery: clinical pharmacokinetic and therapeutic implications PO Gubbins, KE Bertch Clinical pharmacokinetics 21, 431-447, 1991 | 86 | 1991 |
| Clinically relevant drug interactions of current antifungal agents PO Gubbins, S Heldenbrand Mycoses 53 (2), 95-113, 2010 | 84 | 2010 |
| Rapid and sensitive high performance liquid chromatographic method for the determination of itraconazole and its hydroxy-metabolite in human serum PO Gubbins, BJ Gurley, J Bowman Journal of pharmaceutical and biomedical analysis 16 (6), 1005-1012, 1998 | 82 | 1998 |
| Academic help-seeking behavior among student pharmacists N Payakachat, PO Gubbins, D Ragland, SE Norman, SK Flowers, ... American journal of pharmaceutical education 77 (1), 7, 2013 | 75 | 2013 |
| Candidal urinary tract infections: a comprehensive review of their diagnosis and management PO Gubbins, SC Piscitelli, LH Danziger Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 13 (2 …, 1993 | 69 | 1993 |
| Drug–drug interactions of antifungal agents and implications for patient care PO Gubbins, JR Amsden Expert Opinion on Pharmacotherapy 6 (13), 2231-2243, 2005 | 68 | 2005 |
| Blastomycosis in children GE Schutze, SL Hickerson, EM Fortin, DE Schellhase, T Darville, ... Clinical infectious diseases 22 (3), 496-502, 1996 | 67 | 1996 |
| Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy SA McConnell, SR Penzak, TS Warmack, EJ Anaissie, PO Gubbins Clinical infectious diseases 31 (6), 1512-1514, 2000 | 63 | 2000 |
| Grapefruit juice decreases the systemic availability of itraconazole capsules in healthy volunteers SR Penzak, PO Gubbins, BJ Gurley, PL Wang, M Saccente Therapeutic drug monitoring 21 (3), 304, 1999 | 63 | 1999 |
| Antifungal therapy PO Gubbins, EJ Anaissie Clinical mycology, 161-195, 2009 | 60 | 2009 |
| Triazole antifungal agents drug–drug interactions involving hepatic cytochrome P450 PO Gubbins Expert opinion on drug metabolism & toxicology 7 (11), 1411-1429, 2011 | 58 | 2011 |
| Current management of funguria O Gubbins, A McConnell, R Penzak American journal of health-system pharmacy 56 (19), 1929-1935, 1999 | 58 | 1999 |
